Literature DB >> 16705523

Autoimmune retinal dysfunction in sarcoid chorioretinopathy.

A Koestinger1, Y Guex-Crosier, F-X Borruat.   

Abstract

BACKGROUND: Visual loss, photophobia and night-blindness in a middle-aged patient with a previous history of cancer are highly suggestive of cancer-associated retinopathy. HISTORY AND SIGNS: A 63-year-old man complained of slowly progressive bilateral visual loss, photophobia and night-blindness. His past medical history was remarkable for surgical and medical treatment of a carcinoma of the base of his tongue nine years earlier. Visual acuity was 0.3 RE and 0.15 LE, with constricted visual field in both eyes. Ocular examination and fluorescein angiography were non-relevant. Electroretinography revealed diffuse cone and rod dysfunction. ICG angiography showed multiple small widespread hyperfluorescent spots. A chest CT scan revealed multiple focal lesions which were biopsied. Histological diagnosis was sarcoidosis. THERAPY AND OUTCOME: Upon systemic steroid therapy, visual function gradually improved, and ICG anomalies disappeared. Vision recovered to 1.0 RE and 0.8 LE with normal visual field in both eyes.
CONCLUSION: Sarcoidosis may present as an autoimmune retinal dysfunction with photophobia and night blindness as the presenting symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16705523     DOI: 10.1055/s-2006-926580

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  Depletion of Retinal Dopaminergic Activity in a Mouse Model of Rod Dysfunction Exacerbates Experimental Autoimmune Uveoretinitis: A Role for the Gateway Reflex.

Authors:  Andrea Stofkova; Miloslav Zloh; Dominika Andreanska; Ivana Fiserova; Jan Kubovciak; Jan Hejda; Patrik Kutilek; Masaaki Murakami
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

Review 2.  Autoimmunity in visual loss.

Authors:  Axel Petzold; Sui Wong; Gordon T Plant
Journal:  Handb Clin Neurol       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.